AAS Personalization Guide — Bloodwork & Pharmacogenomics

AAS Personalisation Guide — Bloodwork & Pharmacogenomics Clinical Reference Document · Bodybuilding with Aaron

Your genetics determine how you metabolise every compound you run. Your bloodwork tells you whether your body is handling it. Most people ignore both.

The AAS Personalisation Guide is a comprehensive interactive reference built around one principle: the best cycle is the one designed around your individual biology — not someone else's protocol copy-pasted from a forum.

Covering 17 compounds across all major classes, 20+ bloodwork markers, and 9 pharmacogenomic profiles, this guide gives you the clinical framework to understand exactly how your CYP enzyme phenotype, androgen receptor sensitivity, lipid genetics, and cardiovascular risk profile should shape every decision — from compound selection and starting dose, to ancillary management and PCT architecture.

Beyond individual markers and compounds, the guide maps the correlations that matter — the patterns that emerge only when bloodwork and genetics are read together — and translates those patterns directly into cycle-decision logic.

Whether you're running your first informed cycle, optimising an advanced protocol, or building harm reduction frameworks for clients, this guide gives you the tools to stop guessing and start applying real pharmacogenomic science.

What's inside:

• 17 compound profiles with anabolic/androgenic indices, aromatisation rates, CYP enzyme involvement, half-lives, SHBG binding, dosing guidance, and compound-specific bloodwork markers
• 20+ baseline bloodwork markers with pre-cycle optimal ranges, on-cycle targets, and absolute red flag thresholds
• 9 pharmacogenomic profiles — CYP19A1, CYP3A4/5, CYP2C9, AR CAG repeat, APOE, MTHFR, ACE/AGTR1, SLCO1B1 — with full poor/intermediate/extensive/ultrarapid metaboliser phenotype tables and direct cycle implications
• Complete on-cycle monitoring schedule from baseline through post-PCT, with adjustment triggers for every marker
• 12 ancillary protocols with bloodwork-driven dosing thresholds — not blanket prophylactic recommendations
• 14 pattern → cycle decision mappings based on your bloodwork and genetic phenotype
• 8 PCT and recovery protocols for every post-cycle scenario

Harm reduction first. Clinical depth throughout. No fluff. Just the framework.

For educational use only. Always interpret in a clinical context. Produced by Bodybuilding with Aaron using Claude AI.